ARTS-HF (Completed)
A randomized, double-blind, double-dummy, multi-center study to assess safety and efficacy of BAY 94-8862 in chronic heart failure with left ventricular systolic dysfunction and type 2 diabetes mellitus and / or chronic kidneydisease versus eplerenone.
- Medicine
- BAY 94-8862
- Population
- Heart failure
- Phase
- IIb
- Starting year
- 2012
- More information
- ClinicalTrials.gov